 |
|
 |
 |

Home > Company Index > Drugs > Biotechnology-Research > Orchid BioSciences, Inc.
 |
Orchid BioSciences, Inc. |
 |
 |
 |
NEWS FROM THE WIRES |
 |
UK lab wins contract for sheep disease project Aug 08 2001 05:48 AM PDT
> More WIRE STORIES about this company
NEWS FROM THE STANDARD |
 |
Designer Drugs
May 21 2001 12:00 AM PDT
PROFILE |
 |
Orchid BioSciences helps genetic research bloom. Its SNP-IT technology focuses on single nucleotide polymorphisms (SNPs), substances within DNA that indicate genetic diversity, to enhance drug discovery and efficacy. Its primary product, the SNPstream system, searches for specific SNPs on DNA strands, identifying possible sites for drug interactions. The firm also sells test kits and high-throughput SNP scoring services. It has collaborative agreements with such firms as Affymetrix, Eli Lilly, and the SNP Consortium. About 65% of the firm's revenues, however, comes from genetic testing services. Orchid BioSciences' GeneScreen and Cellmark Diagnostics subsidiaries provide forensic and paternity genetic testing.
COMPETITION |
 |
Celera Genomics Group (CRA)
Millennium Pharmaceuticals, Inc. (MLNM)
Variagenics, Inc. (VGNX)
|
 |
STOCK ANALYSIS |
 |
FURTHER ANALYSIS
Advanced Charting
Deals
FINANCIAL OVERVIEW |
 |
Fiscal Year-End: December
2000 Sales (mil.): 18.40
1-Yr. Sales Growth: 922.2%
Employees: 344
Revenue per employee: $53,488.37
KEY PEOPLE |
 |
Dale R. Pfost
CEO
Donald R. Marvin
CFO
CONTACT INFO |
 |
303 College Road East
Princeton, NJ 08540
US
Phone: 609-750-2200
Fax: 609-750-2250
Online: Web Site
|
 |
 |
 |
|
Hoover's Company Capsule
Copyright © 2001, Hoover's Inc. Austin, Texas.
For changes and updates, contact Hoover's directly.
|

|
 |
 |
|
 |